ArticleOncotarget2014

The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib.

Wen-Quan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.